Merkel cell carcinoma recurrence risk is lower in patients with autoimmune disease than in those with other types of immune suppression

被引:0
|
作者
Park, S. Y. [1 ]
Hippe, D. [1 ]
Zawacki, L. [1 ]
Bierma, M. [1 ]
Bhatia, S. [1 ]
Zaba, L. [2 ]
Nghiem, P. [1 ]
Singh, N. [1 ]
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] Stanford Univ, Stanford, CA 94305 USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
179
引用
收藏
页码:S30 / S30
页数:1
相关论文
共 40 条
  • [31] Improved Overall Survival in Patients Treated with Adjuvant Radiation Therapy to the Primary Tumor for Stage I Merkel Cell Carcinoma Less than 1cm in Size Without Adverse Risk Factors
    Fischer-Valuck, B. W.
    Kahn, S. T.
    Rao, Y. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E7 - E7
  • [32] Detection of hypermethylated SHOX2 in circulating cell-free DNA post nephrectomy identifies patients with renal cell carcinoma at highest risk for disease recurrence independent of TNM
    Buettner, T.
    Zarbl, R.
    Krausewitz, P.
    Strieth, S.
    Kristiansen, G.
    Eckstein, M.
    Ralser, D.
    Hoelzel, M.
    Ritter, M.
    Ellinger, J.
    Dietrich, D.
    Kluemper, N.
    EUROPEAN UROLOGY, 2023, 83
  • [33] Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease
    Korzenik, Joshua
    Larsen, Michael Due
    Nielsen, Jan
    Kjeldsen, Jens
    Norgard, Bente Mertz
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (03) : 289 - 294
  • [34] Bevacizumab (BEV) and the risk of arterial thromboembolic evets (ATE) in patients with renal cell carcinoma and other cancers: A large comprehensive meta-analysis of more than 13,000 patients
    Azzi, G. R.
    Schutz, F. A.
    Je, Y.
    Choueiri, T. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Letter: increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than IBD
    Dai, Cong
    Jiang, Min
    Sun, Ming-Jun
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (07) : 834 - 835
  • [36] Predictors of disease recurrence in high-risk non-metastatic renal cell carcinoma patients post-surgical resection A single-center, retrospective study
    Taneja, Shipra
    Bonert, Michael
    Hoogenes, Jen
    Matsumoto, Katelyn
    Shayegan, Bobby
    Matsumoto, Edward D.
    Lambe, Shahid
    Piercey, Kevin
    Kapoor, Anil
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2024, 18 (03): : E53 - E58
  • [38] Correlations between disease-free survival (DFS) and overall survival (OS) in patients (pts) with renal cell carcinoma (RCC) at high risk for recurrence: Results from S-TRAC trial
    George, D. J.
    Pantuck, A. J.
    Figlin, R.
    Escudier, B.
    Halabi, S.
    Casey, M.
    Lin, X.
    Serfass, L.
    Frean, M. J. Lechuga
    Ravaud, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 312 - 312
  • [39] HIV Suppression Restores the Lung Mucosal CD4+ T-Cell Viral Immune Response and Resolves CD8+ T-Cell Alveolitis in Patients at Risk for HIV-Associated Chronic Obstructive Pulmonary Disease
    Popescu, Iulia
    Drummond, M. Bradley
    Gama, Lucio
    Lambert, Allison
    Hoji, Aki
    Coon, Tiffany
    Merlo, Christian A.
    Wise, Robert A.
    Keruly, Jeanne
    Clements, Janice E.
    Kirk, Gregory D.
    McDyer, John F.
    JOURNAL OF INFECTIOUS DISEASES, 2016, 214 (10) : 1520 - 1530
  • [40] Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria
    Hamilton, Zachary A.
    Capitanio, Umberto
    Pruthi, Deepak
    Ghali, Fady
    Larcher, Alessandro
    Patel, Devin N.
    Eldefrawy, Ahmed
    Patel, Sunil
    Cotta, Brittney H.
    Bradshaw, Aaron W.
    Meagher, Margaret F.
    Miller, Nathan S.
    Carenzi, Cristina
    Wan, Fang
    Liss, Michael A.
    McGregor, Thomas
    Montorsi, Francesco
    Derweesh, Ithaar H.
    UROLOGY, 2020, 138 : 60 - 68